- 1 -
Y-mAbs Therapeutics, Inc.
ANTI-BRIBERY, ANTI-CORRUPTION (“ABAC”) AND OFFICE OF FOREIGN
ASSESTS CONTROL (“OFAC”)
POLICY STATEMENT AND COMPLIANCE GUIDE
ABAC
Introduction and Policy Statement
It is the policy of Y-mAbs Therapeutics, Inc., its subsidiaries and affiliates (collectively, the
“Company”) to comply with the U.S. Foreign Corrupt Practices Act (“FCPA”), the United
States Anti-Kickback Statute (“AKS”), physician self-referral laws (“Stark Laws”), the United
States False Claims Act (“FCA”), the United Kingdom Bribery Act 2010 as amended, United
Nations Convention against Corruption (“UNCAC”), the Council of Europe Criminal Law
Convention on Corruption, and the Organization for Economic Cooperation and Development
Anti-Bribery Convention (“OECD Anti-bribery Convention”) and all other applicable anti-
bribery and anti-corruption laws. The Company prohibits bribery and other corrupt practices in
any form, whether committed directly or indirectly, and whether involving government officials
or private parties.
This ABAC and OFAC Policy Statement and Compliance Guide (“Policy”) is not designed to be
all encompassing, but instead is intended to expand and supplement the provisions of the
Company’s existing Code of Conduct, the Company’s various policies on interactions with
Health Care Professionals (“HCPs”) and Health Care Organizations, as well as the PhRMA Code
on Interactions with HCPs. This Policy clearly sets forth the Company’s policy prohibiting any
activity in support of prohibited practices. Additionally, by providing a basic understanding of
the relevant laws, the Policy provides guidance to assist in identifying situations that risk
violating the FCPA, AKS, FCA, or other applicable anti-corruption laws and, therefore, ensure
that appropriate action is taken. If you have any questions about the information contained in
this Policy or if you have any questions about a particular business transaction, you should
contact the Anti-Corruption Compliance Coordinator as discussed below.
Worldwide compliance with this Policy is mandatory. No employee has the authority to act
contrary to or inconsistently with the provisions of this Policy or to authorize, direct or condone
violations of it by any other employee. Similarly, because the Company can be held liable for
payments made on its behalf by third parties, no Company employee may authorize, direct, or
condone any representative, distributor, or affiliate to make such payments. The Company will
require third parties who represent the Company (such as agents, consultants, independent sales
representatives, etc.) to conduct themselves consistently with this Policy, including by complying
with all applicable anti-corruption laws.
No employee shall engage in providing, offering, soliciting, receiving, or accepting any bribe,
kickback, or improper payment or benefit to or from any employee or representative of any
government, vendor, supplier, competitor, or other person or entity in any matter that has to do
with the Company. This prohibition is global in nature – it applies to the Company’s employees,
agents, representatives, and operations everywhere in the world (“Y-mAbs Personnel”).